Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine oral thin film pharmacokinetic and pharmacodynamic study in healthy adults
NL-OMON23379Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of esketamine in acute pain, pain and major depressive disorder (MDD), sponsored by Leiden University Medical Center. Primary endpoint: Plasma concentrations of S-ketamine and S-norketamine. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
acute painpainmajor depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON23379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23379.